MODERATE HEMOPHILIA A

Clinical trials for MODERATE HEMOPHILIA A explained in plain language.

Never miss a new study

Get alerted when new MODERATE HEMOPHILIA A trials appear

Sign up with your email to follow new studies for MODERATE HEMOPHILIA A, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet finished but already full! 1

Three-Year study tests if new hemophilia drug protects joints and boosts activity

Disease control Ongoing

This study is observing people with moderate to severe hemophilia A who are switching to a preventive drug called emicizumab. Researchers want to see how well this long-term treatment protects their joints from damage and helps them stay physically active over three years. The st…

Matched conditions: MODERATE HEMOPHILIA A

Phase: PHASE4 • Sponsor: Hoffmann-La Roche • Aim: Disease control

Last updated Apr 04, 2026 09:20 UTC

MODERATE HEMOPHILIA A

Get alerted when new MODERATE HEMOPHILIA A trials appear

Three-Year study tests if new hemophilia drug protects joints and boosts activity